Finance

Beta
Lists
APVO:NASDAQ
Aptevo Therapeutics Inc
$4.76
-2.66%
(-0.13) 1D
$4.72
-0.84% (-0.040)
Pre-market
Closed: Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APVO...
Open
$4.80
High
$4.98
Low
$4.60
Mkt. cap
5.93M
Avg. vol.
45.21K
Volume
146.00
52-wk high
$235.98
52-wk low
$3.84
EPS
-$204.04
Beta
1.69
Shares outstanding
1.25M
No. of employees
33
Open
$4.80
High
$4.98
Low
$4.60
Mkt. cap
5.93M
Avg. vol.
45.21K
Volume
146.00
52-wk high
$235.98
52-wk low
$3.84
EPS
-$204.04
Beta
1.69
Shares outstanding
1.25M
No. of employees
33
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to APVO in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for APVO in the last 3 months.
Highest
Current $4.76
$21.00 (+341.18%)
Average
$21.00 (+341.18%)
Lowest
$21.00 (+341.18%)
News stories
From sources across the web
About Aptevo Therapeutics Inc
CEO-
Employees33
Founded2016
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteaptevotherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.33M
4.04M
3.54M
3.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90M
3.57M
2.46M
2.91M
Operating expense
6.23M
7.61M
6.00M
6.84M
Total operating expenses
6.23M
7.61M
6.00M
6.84M
Operating income
-6.23M
-7.61M
-6.00M
-6.84M
Other non operating income
22.00K
61.00K
190.00K
140.00K
EBT including unusual items
-6.20M
-7.55M
-5.81M
-6.70M
EBT excluding unusual items
-6.20M
-7.55M
-5.81M
-6.70M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6.20M
-7.55M
-5.81M
-6.70M
Net profit margin
-
-
-
-
Earnings per share
-151.20
-40.14
-
-6.41
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.18M
-7.56M
-5.92M
-6.80M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer